{"id":"W4381158392","doi":"10.1002/ajh.26990","title":"A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (<scp>CARAMEL</scp>)","year":2023,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Carfilzomib; Medicine; Melphalan; Multiple myeloma; Autologous stem-cell transplantation; Clinical endpoint; Internal medicine; Transplantation; Urology; Cohort; Oncology; Adverse effect; Surgery; Lenalidomide; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00117687,0.001123226,0.0009313999,0.0004177361,0.0003764744,0.0005510739,0.0006529164,0.000953624,0.001872935],"category_scores_gemma":[0.0004030908,0.0004848907,0.0007138994,0.0002517922,0.0005014192,0.0004227923,0.0003025162,0.002358343,0.0003272712],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006777698,"about_ca_system_score_gemma":0.001171767,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007151813,"about_ca_topic_score_gemma":0.002079585,"domain_scores_codex":[0.9997118,0.0001416172,0.00001045283,0.00004019088,0.00003500757,0.00006080942],"domain_scores_gemma":[0.9996986,0.00003664706,0.00006603319,0.00002596775,0.00002384217,0.0001489545],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3694225,0.1875419,0.01010479,0.0006671047,0.0009100722,0.0004808572,0.0004261012,0.004779129,0.2628679,0.0006910595,0.008449173,0.1536595],"study_design_scores_gemma":[0.3136614,0.6410854,0.01637361,0.0000368908,0.0003083723,0.000428514,0.00004868788,0.001899217,0.02018302,0.0002194108,0.005728611,0.00002680906],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956802,0.0006465786,0.0004990269,0.000252223,0.00007403395,0.001790161,0.0003808523,0.00005767793,0.0006192426],"genre_scores_gemma":[0.985981,0.001030662,0.003785357,0.000915457,0.0001698415,0.003954169,0.002173864,0.00002228071,0.001967508],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001872935,"threshold_uncertainty_score":0.006265581,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02873460214772766,"score_gpt":0.3382647170175598,"score_spread":0.3095301148698321,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}